CIRIUS THERAPEUTICS Trademark

Trademark Overview

On Thursday, March 23, 2017, a trademark application was filed for CIRIUS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CIRIUS THERAPEUTICS trademark a serial number of 87382718. The federal status of this trademark filing is REGISTERED as of Tuesday, May 8, 2018. This trademark is owned by Octeta Therapeutics, LLC. The CIRIUS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals and therapeutic products for treatment of liver disease
cirius therapeutics

General Information

Serial Number87382718
Word MarkCIRIUS THERAPEUTICS
Filing DateThursday, March 23, 2017
Status700 - REGISTERED
Status DateTuesday, May 8, 2018
Registration Number5465927
Registration DateTuesday, May 8, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2017

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceuticals and therapeutic products for treatment of liver disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2017
Primary Code042
First Use Anywhere DateTuesday, April 11, 2017
First Use In Commerce DateTuesday, April 11, 2017

Trademark Owner History

Party NameCIRIUS THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGRAND RAPIDS, MI 49503
Party NameCIRIUS THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameOcteta Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49007
Party NameOcteta Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressKalamazoo, MI 49007

Trademark Events

Event DateEvent Description
Sunday, April 16, 2017ASSIGNED TO LIE
Monday, March 27, 2017NEW APPLICATION ENTERED
Tuesday, March 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 4, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, April 28, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, June 16, 2017ASSIGNED TO EXAMINER
Friday, June 16, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, June 16, 2017EXAMINERS AMENDMENT E-MAILED
Friday, June 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 16, 2017EXAMINER'S AMENDMENT ENTERED
Friday, June 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 16, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 5, 2018TEAS STATEMENT OF USE RECEIVED
Monday, March 5, 2018USE AMENDMENT FILED
Wednesday, March 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, March 31, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 3, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 8, 2018REGISTERED-PRINCIPAL REGISTER
Monday, May 8, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 6, 2024TEAS SECTION 8 & 15 RECEIVED

Related Keywords

therapeutics cirius treatment liver disease products therapeutic development pharmaceuticals research